Although an increase in cytosolic pH (pHi) caused by Na+/H+ exchange enhances Ca2l mobilization in platelets stimulated by low concentrations of thrombin [Siffert & Akkerman (1987) Nature (London) 325, 456-458], studies using fluorescent indicators for pHi (BCECF) and [Ca2"]i (fura2) suggest that Ca2" is mobilized while the cytosolic pH decreases. Several lines of evidence indicate that the initial fall in BCECF fluorescence is not due to cytosolic acidification but is caused by a platelet shape change. (1) Pulse stimulation of platelets by successive addition of hirudin (4 unit/ml) and thrombin (0.2 unit/ml) induced a shape change of 43+80% and a fall in BCECF fluorescence, which both remained unchanged when Na+/H+ exchange was inhibited by ethylisopropylamiloride (EIPA, 100 tM). (2) Increasing the thrombin concentration to 0.4 unit/ml doubled the shape change and the fall in BCECF fluorescence, but again EIPA had no effect on these responses. (3) Treating platelets with 2,aM-ADP induced shape change and a decline in BCECF fluorescence that was unaffected by EIPA. (4) A second addition of thrombin to platelets that had already undergone shape change induced an immediate increase in BCECF fluorescence without a prior decrease. (5) Activation of protein kinase C by 1,2-dioctanoyl-sn-glycerol (DiC8) neither induced shape change nor a decline in BCECF fluorescence; in contrast BCECF fluorescence rapidly increased indicating an immediate cytosolic alkalinization. Concurrent analysis of [Ca2+]i under conditions in which shape change did not interfere with BCECF fluorescence showed that cytosolic alkalinization and Ca2+ mobilization started almost simultaneously. These observations suggest that cytosolic alkalinization is not preceded by a fall in pHi and can support Ca2" mobilization induced by weak agonists.
INTRODUCTION
An early event in thrombin-stimulated platelets is a cytosolic alkalinization mediated by Na+/H+ exchange (Horne et al., 1981; Zavoico et al., 1986; Siffert et al., 1987a) . Two lines of evidence indicate that this rise in cytosolic pH (pHi) supports agonist-induced Ca2" mobilization from intracellular storage sites. First, studies with permeabilized platelets have revealed that the inositol 1,4,5-trisphosphate [Ins(1,4,5)P3]-induced release of Ca2" is pH-dependent. Elevating the pH of the suspending medium from 7.1 to 7.4 enhances Ca2" release, especially at low concentrations of Ins(1,4,5)P3 (Brass & Joseph, 1985) . Secondly, studies on intact platelets loaded with the intracellular fluorescent Ca2" dye quin2 have shown that inhibition of Na+/H+ exchange reduces thrombininduced Ca2" mobilization. Artificial cytosolic alkalinization, on the other hand, amplifies the thrombininduced rise in the cytosolic free Ca2" concentration ([Ca2+] i) (Siffert & Akkerman, 1987; Siffert et al., 1987b ). This pH,-dependence of thrombin-induced Ca2" mobilization is especially seen at low agonist concentrations (< 0.1 unit/ml), but diminishes at higher thrombin concentrations (Sage & Rink, 1986; Zavoico et al., 1986; Hunyady et al., 1987; Siffert & Akkerman, 1987; Simpson & Rink, 1987; Sanchez et al., 1988) .
In contrast, studies with fluorescent indicators for both cytosolic pH (e.g. BCECF) and Ca2" (fura2) suggest that Ca2" is mobilized while pH, decreases (Zavoico et al., 1986; Rink, 1987; Simpson & Rink, 1987; Funder et al., 1988; Sanchez et al., 1988) . In the present study we have attempted to resolve this apparent discrepancy.
EXPERIMENTAL Materials Fura2-acetoxymethylester (fura2-am) was purchased from Calbiochem (Frankfurt, Germany) . 2,7-Bis-(2-carboxethyl)-5(6)-carboxyfluorescein tetraacetoxymethylester (BCECF-am) was obtained from HSC Research Development Corporation (Toronto, Canada). Both indicators were stored frozen as 5 mM-stock solutions in dimethyl sulphoxide. Ethylisopropylamiloride (EIPA) was provided by Dr. T. Friedrich (Max-Planck-Institut fur Biophysik, Frankfurt, Germany) . A 50 mM-stock solution was prepared in dimethyl sulphoxide. Thrombin (bovine), hirudin, 1,2-Vol. 258
Abbreviations used: pHi, cytosolic pH; Ins(I,4,5)P3, inositol 1,4,5-trisphosphate; [Ca21] i, cytosolic free Ca2+ concentration; BCECF, 2,7-bis-(2-carboxethyl)-5(6)-carboxyfluorescein; EIPA, ethylisopropylamiloride; DiC8, 1,2-dioctanoyl-sn-glycerol; PRP, platelet-rich plasma; F, fluorescence; Na+O, extracellular Na+. dioctanoyl-sn-glycerol (DiC8), ionomycin, monensin, nigericin and prostaglandin 12 were obtained from Sigma. All other chemicals were of analytical grade and obtained from Sigma or Merck (Darmstadt, Germany). Preparation of platelet-rich plasma Venous blood was obtained from healthy human volunteers who denied having taken any medication for the previous 2 weeks. The blood was anticoagulated by addition of 0.2 vol. of acid citrate/dextrose (2.5 g of sodium citrate, 1.5 g of citric acid and 2.0 g of glucose in 100 ml of distilled water). Platelet-rich plasma (PRP) was obtained by centrifugation of blood at 200 g for 15 min at room temperature. The upper two-thirds of the supernatant was used for the preparation of either fura2-or BCECF-loaded platelets.
Measurement of ICa2"Ii [Ca2+] i was determined after loading platelets with the fluorescent dye fura2 essentially as described by Pollock et al. (1986) . PRP was incubated with 2,uM-fura2-am for 45 min at room temperature. Thereafter, 1 ,UMprostaglandin I2 was added and the PRP was centrifuged at 700 g for 20 min. The supernatant plasma was discarded and the platelet pellet was resuspended in Hepes buffer, pH 7.4, at 37°C, consisting of 140 mMNaCl, 5 mM-KCl, 5 mM-KH2PO4, 1 mM-MgSO4, 10 mMHepes (free acid) and 5 mM-glucose. The platelet concentration in these stock suspensions was 5 x 109/ml.
Samples of these suspensions (approx. 40-50 ll) were then transferred to a cuvette containing 2 ml of Hepes buffer and prewarmed to 37°C for 5 min. Measurements of the fura2 fluorescence were performed in a SFM 25 spectrofluorimeter (Kontron, Dusseldorf, Germany) equipped with a thermostated cell holder and a stirring device. Immediately before addition of agonist, 1 mM-EGTA was added to chelate extracellular Ca2 , making all fura2 signals in the present study solely dependent on the mobilization of Ca2+ from internal storage sites. Agonist was added directly to the cuvette through a hole in the cover of the apparatus while continuously stirring the sample. The monochromator settings were 339 nm for excitation and 500 nm for emission, respectively. After each single experiment the fura2 responses were calibrated to obtain [Ca2+]i by the following procedure.
The cells were lysed with 50 gM-digitonin followed by addition of 1 mM-CaCl2 to obtain the maximal fluorescence, Fmax. Thereafter, the pH of the lysed cells was adjusted to 8.5 with 20 mM-Tris base followed by the addition of 10 mM-EGTA to yield the Ca2+-independent fluorescence of fura2, Fmin. [Ca2+] was then calculated according to the formula:
where F reflects the fura2 fluorescence of resting or stimulated platelets. Kd was taken to be 224 nM (Grynkiewicz et al., 1985; Pollock et al., 1986) . No platelet aggregation occurred in these experiments. Measurement of pH; Cytosolic pH was determined using the intracellularly trappable fluorescent pH indicator BCECF (Rink et al., 1982) . Pelleted platelets prepared from PRP as described above were resuspended in Hepes buffer (see above), pH 6.5. BCECF-am (final concn. 10 gM) was added and the cells were incubated for 30 min at 37 'C. Thereafter, 1 ,aM-PGI2 was added and the platelets were then washed twice in Hepes buffer, pH 6.5, by repeated centrifugation at 650 g for 20 min and resuspension at room temperature. After the last washing step, the final pellet was taken up into Hepes buffer, pH 7.4, at a concentration of S x 109 cells/ml. Samples of these suspensions (30-40 ,tl) were then transferred to 2 ml of Hepes buffer in a cuvette and prewarmed at 37 'C. Other details of the experimental conditions were identical to those for the Ca21 measurements. The fluorescence of BCECF was measured using wavelengths for excitation and emission of 495 nm and 530 nm respectively. The calibration of the fluorescence signals was carried out by (1) suspending platelets in high K+/nigericin medium at defined pH values, and by (2) lysis of platelets with 50 /iM-digitonin followed by adjustment of the pH to defined values exactly as described in the literature (e.g. Rink et al., 1982; Zavoico et al., 1986; Siffert et al., 1987a ).
Measurement of shape change
Platelet shape change was measured in a Chronolog P.I.C.A. aggregometer and quantified as described in the literature (Latimer et al., 1977; Holme & Murphy, 1978; Patscheke et al., 1984; Verhoeven et al., 1985) . Briefly, PGI2-treated pelleted platelets were resuspended in Hepes buffer, pH 7.4, at a concentration of 1 x 108 cells/ ml. After prewarming the suspensions to 37 'C, the platelets were transferred to the aggregometer and intermittently stirred at 100 and 800 rev./min. Lowering the stirring speed to 100 rev./min increased the absorbance of the suspensions, whereas at 800 rev./min the absorbance decreased. The difference in absorbance measured at both stirring speeds, which reflects the sphere-disc transformation, was used to quantify the shape change observed after addition of agonists (Verhoeven et al., 1985) . All measurements were performed in the presence of 2 mM-EDTA added immediately before addition of agonist to prevent platelet aggregation.
Manipulation of Na+/H+ exchange Two methods were used to inhibit the platelet Na+/H+ exchanger. First, the Na+ of the final Hepes buffer was iso-osmotically replaced by choline chloride. In these experiments the platelets were kept as a concentrated suspension (approx. 5 x 109 cells/ml) in 140 mMNa+ medium in order to prevent spontaneous cytosolic acidification. Samples (approx. 50 ,ul) were then added to 2 ml of Na+-free Hepes buffer, pH 7.4. Thus, the final Na+ concentration was approx. 3 mm, which inhibits Na+/H+ exchange by about 9000 (Siffert et al., 1987a) .
Secondly, the exchanger was inhibited by addition of 100 UM-EIPA which is thought to be a rather specific blocker of this ion transport (Vigne et al., 1983; Besterman et al., 1985) , although recent reports point at a few significant side effects (Simchowitz et al., 1987; Yoshida et al., 1988 (Verhoeven et al., 1985) . Under these conditions thrombin is rapidly bound by hirudin, leaving only a short period in which it can activate the platelets. Fig. 2 illustrates a comparison between BCECF and fura2 signals and changes in the absorbance of platelet suspensions preincubated with 4 units of hirudin/ml and subsequently stimulated by 0.2-0.4 unit of thrombin/ml. In the absence of hirudin, the platelets are disc-shaped as illustrated by an increase in absorbance of the suspension when the stirring speed is decreased from 800 to 100 revs./min. (Fig. 2a, lower panel) . Activation of platelets by 0.2 unit of thrombin/ml again resulted in a sharp fall in BCECF fluorescence that was followed by an increase.
The same treatment raised [Ca2+]i to 560 + 44 nm. Under similar conditions, 0.2 unit of thrombin/ml induced complete shape change as indicated by an increase in the absorbance which thereafter was independent of the stirring speed. When the platelets were incubated with 4 units of hirudin/ml before stimulation with 0.2 unit of thrombin/ml (Fig. 2b) , the BCECF fluorescence declined and remained low after 30 s. This process was not accompanied by Ca2`mobilization. However, the absorbance of the suspension increased, and within 30 s a platelet shape change of 43 + 80 (n = 6) had occurred.
In order to investigate whether the initial decrease in BCECF fluorescence represented a true fall in pHi caused by an increased intracellular H+ generation, the same experiment was performed after inhibition of Na+/ H+ exchange by 100 /JM-EIPA. Fig. 2 (c) illustrates that EIPA had no effect on the thrombin-induced BCECF response. Furthermore, Ca2`mobilization was not detectable and the shape change averaged 34 + 170% (n = 7) which is not significantly different from that observed in the absence of EIPA (P > 0.3). Increasing the thrombin concentration to 0.4 unit/ml (Fig. 2d) enhanced the fall in BCECF fluorescence by a factor of 2.3 + 0.3 (n = 6). Again, [Ca2+]i did not change, but shape change amounted to 92 + 180 (n = 7). These observations were not affected by addition of 100 tM-EIPA (Fig. 2e) , except for a slightly smaller shape change, to 69+18 % (n = 7; P < 0.05). These findings suggest that the initial fall in BCECF fluorescence is not caused by cytosolic acidification since it is not potentiated by EIPA. In contrast, there is a close correlation between the changes in BCECF fluorescence and platelet shape change.
Next, we investigated the effect of a second stimulation of platelets that had already undergone shape change after the sequential treatment with hirudin and a low concentration of thrombin. Fig. 3 (a) shows that addition of 0.4 unit of thrombin/ml to platelets pretreated with 4 units of hirudin/ml again decreased the BCECF fluorescence without raising [Ca2+] in Fig. 1 . Platelets were suspended in 140 mM-Na' medium in the presence of 1 mM-EGTA or 2 mM-EDTA, and pretreated with 4 unit of hirudin/ml (H), followed by addition of 0. with 0.4 unit of thrombin/ml, shape change was almost complete. No further change in absorbance occurred at the time when BCECF and fura2 fluorescence changed. When the same procedure was repeated after blockade of Na+/H+ exchange with 100 ,tM-EIPA (Fig. 3b) , the second addition of thrombin caused an abrupt fall in BCECF fluorescence suggesting a decrease in pHi by 0.40 + 0.05 unit (n = 6). In these cells, Ca2m obilization was almost negligible (9 + 3 o of control; n = 7). A similar series of experiments was carried out with platelets that had completed shape change after stimulation with a low concentration of ADP. The results are shown in Fig. 4 . Upon addition of 2 ,uM-ADP to BCECF-loaded platelets, the fluorescence decreased within 20-30 s, and thereafter remained stable for at least 5 min (Fig. 4a) . This response was accompanied by a small increase in [Ca2+]i amounting to 26 + 14 nM (n = 6) above the resting value, and by a 94 + 120% (n = 6) shape change. Addition of 0.1 unit of thrombin/ ml 2-5 min after ADP evoked an immediate rise in BCECF fluorescence indicative of a rise of pHi by 0.26 + 0.08 unit, as well as an increase in [Ca2+] , to 282 + 36 nM (n = 4). In platelets pretreated with 100 ,tM-EIPA (Fig. 4b) the ADP-induced fall in BCECF fluorescence and shape change remained unaffected, whereas Ca2`mobilization was completely suppressed. Addition of 0.1 unit of thrombin/ml to these platelets caused a further drop in BCECF fluorescence equivalent to a decrease in pHi of 0.18 +0.03 unit (n = 7). The thrombin-induced rise in [Ca2+]i was strongly reduced and amounted to 79 + 22 nM (n = 3). Finally, we investigated how activation of protein kinase C by DiC8, which is known not to induce immediate shape change (Friesen & Gerrard, 1985) , affected the BCECF fluorescence. Activation of protein kinase C by 25 guM-DiC8 (Fig. 5) increased the BCECF fluorescence without a preceding fall, and the final increase in pHi amounted to 0.17 + 0.05 unit (n = 6) above the resting value. Neither Ca2`mobilization nor any changes in the suspensions' absorbance occurred upon this treatment.
DISCUSSION Shape change decreases BCECF fluorescence without a change in pH;
The present study shows that the initial decrease in BCECF fluorescence is not a reflection of cytosolic acidification but is caused by platelet shape change which changes the light-transmitting properties of the cell suspension. This conclusion is based on the following observations: 1. The time course of the decrease in BCECF fluorescence paralleled that of shape change. Thereafter, the BCECF signals remained stable and did not return to original values although the Na+/H+ exchanger was not inhibited. This is in strict contrast to what one observes if the cytosol is artificially acidified (e.g. by nigericin), since the increase in intracellular H+ is rapidly counteracted by an increased activity of the Na+/H+ antiport (Zavoico et al., 1986 2. Addition of a second dose of thrombin to platelets that had already undergone shape change after either pulse activation (by pretreatment with thrombin/hirudin) or addition of ADP did not induce a second decrease in BCECF fluorescence in the absence of EIPA (Figs. 3a  and 4a ). In contrast, under these conditions, the BCECF fluorescence increased instantly after thrombin addition, except when the Na+/H+ exchanger was inhibited. 3. Activation of protein kinase C by DiC8 neither induced immediate shape change, in agreement with the literature (Rink et al., 1983; Friesen & Gerrard, 1985; Lapetina et al., 1985) , nor led to a decrease in BCECF fluorescence. In contrast, the BCECF fluorescence increased promptly upon this treatment (Fig. Sb) . BCECF and measurement of pH;
The effect of shape change on BCECF fluorescence leads to a significant underestimation of the agonistinduced alkalinization in human platelets. Similar problems are likely to arise in ADP-stimulated platelets (Sweatt et al., 1986) . This may explain why Funder et al. (1988) (Zavoico et al., 1986; Siffert et al., 1987a) . It should be stressed that shape change increases the fall in BCECF fluorescence after blockade of Na+/ H+ exchange by EIPA and thus leads to an overestimation of the actual fall in pHi (Fig. 3b ).
An alternative way to correct BCECF fluorescence for interference by shape change has been proposed by Davies et al. (1987) , who recorded the fluorescence with excitation at 500 nm for maximal pH-sensitive emission and at 450 nm, the isosbestic wavelength at which there are no pH-induced changes. Unfortunately, the intensity of emitted light at an excitation wavelength of 450 nm is much lower than at 500 nm which complicates estimation of the contribution of shape change to total fluorescence changes. We found no effect of shape change on the fluorescence of fura2. The signal-to-noise ratio is rather low in BCECF-loaded platelets as compared to fura2-loaded platelets. Under our experimental conditions the fluorescence of BCECF-loaded platelets is about ten-fold higheL than the autofluorescence of unlabelled cells, whereas for fura2-loaded platelets this ratio is at least 30.
It is also possible to alter the light-transmitting properties of the platelet suspension by inducing hypoosmotic swelling. In preliminary experiments we found that decreasing the osmotic strength of the incubation buffer by 30 % reduced the decrease in BCECF fluorescence by more than 800 but left rapid alkalinization intact. However, this procedure also induced platelet lysis. Furthermore, artificial manipulation of the cell volume may itself alter the activity of the Na+/H+ exchanger (for review see Grinstein & Rothstein, 1986) , so this method was not routinely employed.
It is noteworthy that similar decreases in BCECF fluorescence have been observed in suspensions of various other cells upon activation. The stimulation of vascular smooth muscle cells with thrombin, Ca2+ ionophore and angiotensin II has been reported to induce an initial acidification followed by alkalinization due to Na+/H+ exchange (Berk et al., 1987a,b; Hatori et al., 1987; Huang et al., 1987) . Interestingly, when these cells were activated with phorbol ester or 1-oleoyl-2-acetylglycerol, no initial decrease in BCECF fluorescence was detectable, which resembles our observations in platelets. Also, activation of BCECF-loaded neutrophils with the chemotactic peptide fMet-Leu-Phe resulted in an initial fall in fluorescence, followed by a later increase (Grinstein & Furuya, 1984; Molski & Sha'afi, 1987; Weisman et al., 1987) . It would be interesting to re-investigate whether activation of these cells by different agonists actually acidifies the cytosol or whether early occurring changes in cell morphology, such as swelling, interfere with the measurement of pHi.
Interrelationship between Na+/H+ exchange and Ca2" mobilization In conditions where the influence of shape change on changes of BCECF fluorescence was largely eliminated, we found that cytosolic alkalinization and Ca2+ mobilization started almost simultaneously (Figs. 3a and  4a) . When under these conditions Na+/H+ exchange was inhibited by EIPA, activation of platelets by thrombin caused cytosolic acidification and a concomitant reduction of Ca2+ mobilization (Figs. 3b and 4b) . Hence, the present data strengthen our earlier findings that activation of Na+/H+ exchange enhances the rise in [Ca2"]i in thrombin-stimulated platelets (Siffert & Akkerman, 1987 , 1988a . This effect would be abolished by EIPA or, more specifically, by removal of extracellular Na+ (Siffert & Akkerman, 1987; Ghigo et al., 1988) . It should-be noted, however, that the increase in fura2 fluorescence is still somewhat faster than the increase in BCECF fluorescence. This agrees with recent observations by Zavoico & Cragoe (1988) , who included both fura2 and BCECF in the same platelet preparation. A more precise analysis of both events awaits more accurate analysis, e.g. by stopped-flow spectrofluorimetry.
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